Location of Repository

Hypoxia-Induced Down-Regulation of microRNA-34a Promotes EMT by Targeting the Notch Signaling Pathway in Tubular Epithelial Cells

By Rui Du, Wenjuan Sun, Lin Xia, Ali Zhao, Yan Yu, Lijuan Zhao, Hanmin Wang, Chen Huang and Shiren Sun
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3281867
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles



    1. (2008). A double-negative feedback loop between ZEB1–SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition.
    2. (2007). A microRNA signature of hypoxia.
    3. (2006). A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA).
    4. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method.
    5. (2011). Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia.
    6. (2004). Bertra ´n E, Pe ´rez-Pomares
    7. (2004). Bo ¨ttinger EP
    8. (2005). Children’s Oncology Group. Chromosome 1p and 11q deletions and outcome in neuroblastoma.
    9. (2006). Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure.
    10. (1995). Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer.
    11. (2010). E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta.
    12. (2010). Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans.
    13. (2004). Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention.
    14. (2010). Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function.
    15. (2005). Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines.
    16. (2010). Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers.
    17. (2010). High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells.
    18. (2011). Hypoxia activates the notch signaling pathway in cells of the intervertebral disc: implications in degenerative disc disease.
    19. (2003). Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells.
    20. (2007). Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-tomesenchymal transition.
    21. (2005). Hypoxia requires Notch signaling to maintain the undifferentiated cell state.
    22. (2008). Hypoxia signalling through mTOR and the unfolded protein response in cancer.
    23. (2011). Hypoxia-induced down-regulation of microRNA-449a/b impairs control over targeted SERPINE1 (PAI-1) mRNA-a mechanism involved in SERPINE1 (PAI-1) overexpression.
    24. (2008). Hypoxia-inducible factor signaling in the development of tissue fibrosis.
    25. (2006). Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B.
    26. (2009). Hypoxia-inducible factor1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition.
    27. (2008). Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways.
    28. (2010). Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis.
    29. (2010). Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy.
    30. (2006). Lysyl oxidase is essential for hypoxia-induced metastasis.
    31. (2009). Many roads to maturity: microRNA biogenesis pathways and their regulation.
    32. (2009). MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.
    33. (2003). MicroRNA pathways in flies and worms: Growth, death, fat, stress, and timing.
    34. (2007). MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-b-induced collagen expression via inhibition of E-box repressors.
    35. (2009). miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
    36. (2011). miR200a prevents renal fibrogenesis through repression of TGF-b2 expression.
    37. (2010). miR200b precursor can ameliorate renal tubulointerstitial fibrosis.
    38. (2006). MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia.
    39. (2004). Notch oncoproteins depend on gamma-secretase/presenilin activity for processing and function.
    40. (2004). Notch signaling: the demise of elegant simplicity.
    41. (2006). Notch signalling: a simple pathway becomes complex.
    42. (2008). Notch1 is an effector of Akt and hypoxia in melanoma development.
    43. (2007). Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung.
    44. (2009). Pathophysiological Consequences of HIF Activation: HIF as a modulator of fibrosis.
    45. (2007). Regulation of microRNA Expression.
    46. (1995). Signaling downstream of activated mammalian Notch. Nature 377: 355–358.
    47. (2005). SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions.
    48. (2008). Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo.
    49. (2011). The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
    50. (2008). The microRNA-200 family regulates epithelial to mesenchymal transition.
    51. (2010). The miR-34 family in cancer and apoptosis.
    52. (2008). The miR200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.
    53. (2008). The Notch pathway in podocytes plays a role in the development of glomerular disease.
    54. (2007). The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity.
    55. (2002). Transforming growth factor-beta induces renal epithelial jagged-1 expression in fibrotic disease.
    56. (2007). Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells.
    57. (2010). URG11 mediates hypoxiainduced epithelial-to-mesenchymal transition by modulation of E-cadherin and beta-catenin.
    58. (2006). Versican mediates mesenchymal-epithelial transition.
    59. (2007). VHL promotes E2 box-dependent E-cadherin transcription by HIF mediated regulation of SIP1 and Snail.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.